About Kolmar Pharm
Kolmar Pharm is a Healthcare company based in Seoul (South Korea) founded in 1990, and was acquired by IMM Private Equity in May 2020. CMO engaged in the manufacturing of pharmaceuticals, cosmetics and functional health foods. Kolmar Pharm has completed 1 acquisition, including CSR Cosmetic Solutions. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation.
Company details
Kolmar Korea, founded as a joint venture with Nihon (Japan) Kolmar, is a CMO specializing in the development and manufacturing of pharmaceuticals and quasi-drugs. The company offers its services right from the stage of formulation development to right until commercial manufacturing. The company also offers analytics, validation, quality assurance, packaging, and distribution services. The company has capabilities for the development and manufacturing of a range of dosage forms such as ointments, external solutions, syrups, solid dosage forms (tablets, capsules), and quasi-drugs. The company had formed joint ventures with pharmaceutical companies such as Kracie (Japan) and Pharmascience (Canada) in 2012.
- Headquarters Seoul, South Korea
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website kolmarpharm.co.kr
- Acquired by IMM Private Equity (May 2020)
- Investors
- Investments & Acquisitions
- Acquired byIMM Private Equity
(May 2020)
Investors in Kolmar Pharm
Kolmar Pharm has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include IMM Investment.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
IMM Investment is recognized as a leading multi-asset alternative investment firm in Asia. | immpe.com | Seoul, South Korea |
Investor details for Kolmar Pharm
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Kolmar Pharm
Kolmar Pharm has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include CSR Cosmetic Solutions.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Cosmetic personal care products are manufactured for various applications. | csrcs.ca | Barrie, Canada | 1953 | Nov 2016 | $21.39M |
Complete acquisition details for Kolmar Pharm
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Kolmar Pharm
3 dated milestones of Kolmar Pharm across 30 years, from founding to its latest funding, stage changes and deals.
- Founded Kolmar Pharm is founded.
- Acquisition Acquires CSR Cosmetic Solutions.
- Exit Acquired by IMM Private Equity.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Kolmar Pharm
Complete news archive for Kolmar Pharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kolmar Pharm
Kolmar Pharm was founded in 1990.
Kolmar Pharm is headquartered in Seoul, South Korea.
Kolmar Korea, founded as a joint venture with Nihon (Japan) Kolmar, is a CMO specializing in the development and manufacturing of pharmaceuticals and quasi-drugs. The company offers its services right from the stage of formulation development to right until commercial manufacturing. The company also offers analytics, validation, quality assurance, packaging, and distribution services. The company has capabilities for the development and manufacturing of a range of dosage forms such as ointments, external solutions, syrups, solid dosage forms (tablets, capsules), and quasi-drugs. The company had formed joint ventures with pharmaceutical companies such as Kracie (Japan) and Pharmascience (Canada) in 2012.
Kolmar Pharm has made 1 acquisition, including CSR Cosmetic Solutions.
Kolmar Pharm has 1 investor. Key investors include IMM Investment.
Yes. Kolmar Pharm was acquired by IMM Private Equity in May 2020.